Grants and Contracts Details
Description
The prior reviews noted many strengths of the initial application, including the experience of the
investigative team, the unique clinical research resource furnished by the University of Kentucky Ovarian
Cancer (OC) screening program, and the productivity of the investigative team during the 4 year project period
to date. Reviewers also noted significant strengths in the research design and procedures, the data and power
analysis plans, the variables and measures chosen for study, and the conceptual framework that guided
selection of study variables. The significance of the topic of study - response to abnormal, yet ultimately
benign, abnormal test results during cancer screening - was also noted. We are grateful for these positive
comments and are confident this revised application retains all strengths noted in the initial reviews.
Two fundamental concerns were paramount in determining the initial evaluation of this continuation
application. In a nutshell, reviewers were concerned the proposed research did not represent a significant and
innovative continuation of our research program. The proposed research was viewed as duplicative and
confirmatory. Given this, the reviewers were disappointed we did not propose an intervention. (Parenthetically,
we should note an intervention study would require a budget that would far exceed the budget limits placed on
competing continuations per NIH policy (Le., 120% of current budget.»
After much careful consideration and discussion of these 2 fundamental concerns, we decided the
observational study proposed in the original application _do_e_s constitute an innovative, significant, and
scientifically meritorious extension of our research program. While we completely agree with the reviewers that
an intervention study is the ultimate goal of our program of research, we respectfully disagree with the
reviewers' conclusion that an intervention study constitutes the _ne_xt_logical step in our research program. We
recognize by rejecting the suggested intervention study, we risk alienating the reviewers right from the get-go.
However, we decided an equally justifiable course of action was to do a much better job in the application of
highlighting the significance, innovation, and importance of our observational study. We made this decision with
some trepidation, of course, but we trust the reviewers will consider carefully the merits of our argument.
Status | Finished |
---|---|
Effective start/end date | 3/1/00 → 6/30/09 |
Funding
- National Cancer Institute: $719,628.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.